Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-06-13)Premium Content

Alkermes Plc (ALKS)

2014-07-23@12:41:17 ET
Potential Alkermes (ALKS) Trade Has 8.15% Downside Protection (FBM)

2014-07-23@08:17:33 ET
Short-term Underperformance Detected in Shares of Ligand Pharmaceuticals in the Biotechnology Industry (LGND, MYGN, CLDX, OREX, ALKS) (F70)

2014-07-22@20:42:11 ET
Alkermes plcCorporate Event Announcement Notice (WSH)

2014-07-22@12:45:23 ET
Alkermes (ALKS) Trading Near $46.69 Resistance Level (FBM)

2014-07-22@05:21:25 ET
Form 144: Filing to Sell 48000 Shares of Alkermes PLC (ALKS) (VKR)

2014-07-22@00:53:22 ET
Alkermes Kicks Off Its Phase 1 Clinical Study of ALKS 8700 (CLM)

2014-07-21@21:55:02 ET
Alkermes plcCorporate Event Announcement Notice (WSH)

2014-07-21@21:47:07 ET
Alkermes plcCorporate Event Announcement Notice (WSH)

2014-07-21@21:18:43 ET
Alkermes plcCorporate Event Announcement Notice (WSH)

2014-07-21@20:39:20 ET
Alkermes plcCorporate Event Announcement Notice (WSH)

2014-07-21@13:41:46 ET
Shares of Alkermes Under Pressure, Down 1.6% (F77)

2014-07-21@10:20:32 ET
Alkermes (ALKS) Showing Bearish Technicals With Support At $43.46 (FBM)

2014-07-18@10:26:58 ET
Alkermes begins Phase 1 clinical study of ALKS 8700 for multiple sclerosis (MTO)

2014-07-17@13:42:05 ET
Alkermes (ALKS) Showing Bearish Technicals With Support At $43.74 (FBM)

2014-07-17@10:48:43 ET
US Patent Issued to Alkermes Pharma Ireland on July 15 for "Methods for treating antipsychotic-induced weight gain" (Massachusetts Inventors) (ABW)

2014-07-17@08:22:20 ET
Bottom 5 Companies in the Biotechnology Industry with the Lowest Relative Performance (LGND, INFI, BCRX, ARIA, ALKS) (F70)

2014-07-17@07:33:58 ET
Form 4: Update Filing for Alkermes PLC (ALKS) (VKR)

2014-07-17@07:00:15 ET
Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple Sclerosis (BIZ)